DC
PCRX icon

Deere & Company’s Pacira BioSciences PCRX Stock Holding History

Deere & Company’s Portfolio PCRX Stock Details PCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-4,497
Closed -$345K – 1136
2015
Q4 		$345K Buy
+4,497
New +$255K 0.02% 684
2015
Q3 		– Sell
-6,933
Closed -$490K – 1017
2015
Q2 		$490K Buy
6,933
+1,738
+33% +$137K 0.03% 660
2015
Q1 		$462K Buy
5,195
+1,037
+25% +$105K 0.02% 660
2014
Q4 		$369K Hold
4,158
– – 0.02% 734
2014
Q3 		$403K Buy
+4,158
New +$405K 0.02% 714

Other funds holding PCRX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $9.69B AUM 55.7% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Deere & Company's PCRX Position: Q1 2016 in Review

Deere & Company sold out of Pacira BioSciences (PCRX) in Q1 2016, closing a stake of 4,497 shares — an estimated $345K sold.

Deere & Company first reported a position in PCRX in Q3 2014 and held it in 5 quarters. The position peaked at $490K in Q2 2015. 180 funds tracked by Wall St. Rank hold PCRX as of Q1 2016.

  • Deere & Company reported no remaining Pacira BioSciences position as of Q1 2016 after selling out during the quarter.
  • Deere & Company sold 4,497 Pacira BioSciences shares in Q1 2016, an estimated $345K.
  • Deere & Company first reported a position in Pacira BioSciences in Q3 2014 and held it in 5 quarters.
  • Deere & Company's Pacira BioSciences position peaked at $490K in Q2 2015.
  • 180 funds tracked by Wall St. Rank held Pacira BioSciences as of Q1 2016.

Based on Deere & Company's 13F filing for Q1 2016, filed 9 May 2016.